Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Novartis Malaysia
      About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor
      Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      healthcare professionals talking
      Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      ESG
      ESG
    • News 
      • Stories 
      • News Archive 
      People at the table with screens
      News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Novartis Malaysia Office
      Careers
      Careers
    • Contact 
    Office Cubicle
    Contact Us

Stories

Story Navigation
  • All Topics
  • Education and Awareness
  • Patient Perspectives
  • Access to Healthcare
icon
  • Heart-Attack-Man
    Education and Awareness
    Sep 20, 2024

    Fake News: High Cholesterol Only Affects Older People!

    Cardiovascular disease is on the rise in Malaysia, with patients presenting this problem eight years earlier than the global average1. The reason for this could be due to the common misperception that “heart attacks only happen in older people”. 

     
    Education and Awareness
  • KeepItPumping
    Education and Awareness
    Jan 31, 2022

    "Keep It Pumping"

    Heart failure affects one in five people, often at a young age. Manage it through exercise and medication to reduce symptoms, stay active, and protect your heart health for the long term.

     

    Education and Awareness
  • Not Alone with Psoriasis
    Education and Awareness
    Jan 31, 2022

    Not Alone with Psoriasis

    Psoriasis patients often face stigma, isolation, and mental health struggles. Break the cycle by learning the facts and showing support to ensure no one has to live in the shadows.

     

    Education and Awareness
  • Psoriasis Inside Out
    Education and Awareness
    Jan 31, 2022

    Turning Perceptions Inside Out

    The #PsoriasisInsideOut campaign uses a unique clothing challenge to build empathy. By wearing clothes inside out, the public can experience the stares patients face and help break social stigma.

     

    Education and Awareness
  • What is Ankylosing Spondylitis
    Education and Awareness
    Jan 31, 2022

    Do you know what is Ankylosing Spondylitis?

    We asked Malaysians if they know about Ankylosing Spondylitis to see how aware they are. Watch as we test public knowledge and shed light on this condition.

     

    Education and Awareness

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2026 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia